U.S. Metals and Mining Stock News

NYSE:BV
NYSE:BVCommercial Services

Is It Time To Reassess BrightView Holdings (BV) After Recent Commercial Services Repricing

If you are wondering whether BrightView Holdings is attractively priced or just a value trap, you are in the right place to unpack what the current share price really reflects. The stock last closed at US$11.81, with returns of 7.2% decline over 7 days, 15.5% decline over 30 days, a 6.3% decline year to date, a 10.9% decline over 1 year, a 102.6% gain over 3 years and a 30.4% decline over 5 years. Taken together, this gives you a mixed picture of how sentiment has shifted over different...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Assessing Trinity Capital (TRIN) After Recent Pullback And Strong Valuation Signals

If you are wondering whether Trinity Capital's current share price reflects its true worth, you are not alone. This article is set up to help you look past the headline numbers and into what the valuation actually implies. The stock last closed at US$14.42, with returns of 7.9% over 1 year and much stronger gains over 3 and 5 years. However, the last 7 and 30 days show declines of 3.3% and 8.8% that may have shifted how investors see the balance between opportunity and risk. Recent coverage...
NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics Expands Hospital Portfolio As Investors Weigh Growth And Valuation

Haemonetics (NYSE:HAE) is expanding its product portfolio in the Hospital division with new technology and acquisitions. The company has fully transitioned from legacy PCS2 plasma collection devices to its NexSys PCS system with Persona Technology. Recent purchases of Attune Medica and OpSens add new capabilities in hospital and interventional cardiology settings. For you as an investor, this shift is about more than one product line. Haemonetics operates across blood management and...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Is It Too Late To Consider Karman Holdings (KRMN) After Its 201% One-Year Surge?

If you are wondering whether Karman Holdings at around US$99.98 is still fairly priced or starting to look stretched, you are not alone. The stock has seen a 25.7% return over the past 30 days, 30.1% year to date, and 201.5% over the last year, with a small 0.6% decline in the most recent 7 days. Recent coverage has focused on Karman Holdings as an evergreen story for investors who want ongoing insight into the stock, with attention on how its share price has moved over different time frames...
NYSE:SNDA
NYSE:SNDAHealthcare

Evaluating Sonida Senior Living (SNDA) Valuation After Strong 1 Year Return And Premium P/S Multiple

Why Sonida Senior Living Is On Investors’ Radar Sonida Senior Living (SNDA) has drawn attention after recent share price swings, with a 1 day return of 4.34% contrasting with a 4.28% decline over the past week. This has prompted closer portfolio reviews. See our latest analysis for Sonida Senior Living. That sharp 1 day share price return of 4.34% comes after a softer 7 day share price return of 4.28%. Sonida Senior Living still has a 90 day share price return of 13.06% and a 1 year total...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Has ACADIA Pharmaceuticals (ACAD) Pullback Opened A New Opportunity For Investors?

If you are wondering whether ACADIA Pharmaceuticals at around US$20.61 is offering good value or just fresh risk, you are in the right place for a closer look at what that price might represent. The share price has seen a 7% decline over the last week, an 8.3% decline over the last month, but a 17.8% return over the last year. This can leave investors questioning whether recent weakness is a setback or a reset after earlier gains. Recent attention on ACADIA has centered on its product...
NYSE:EMN
NYSE:EMNChemicals

Eastman Chemical 2026 Self Help Plan Puts Cost Cuts And Cash First

Eastman Chemical (NYSE:EMN) has rolled out a new 2026 self help plan focused on deeper cost reductions and operational efficiency. The plan also targets expanded capital returns, signaling an intention to keep shareholder payouts in focus alongside internal improvements. Management is positioning the initiative as a material shift in how the company runs its business and allocates cash over the next few years. Eastman Chemical is launching this plan at a time when the stock has faced mixed...
NYSE:VIA
NYSE:VIASoftware

Via Transit Wins Highlight Undervalued Growth Story In Public Transport Digitisation

Via Transportation (NYSE:VIA) reports material improvements in city transit performance in the City of Mobile, including better reliability and staffing outcomes without additional budget. The company expands its work with Transport for West Midlands in the UK, adding Citymapper integration to support future regional transit planning. These developments highlight Via’s growing role as a partner for large scale public transit transformation across multiple geographies. Via Transportation,...
NasdaqGM:MVIS
NasdaqGM:MVISElectronic

MicroVision (MVIS) Is Down 7.0% After Revenue Drop And Narrower Losses In 2025 Results

MicroVision, Inc. has reported its full-year 2025 results, with sales of US$1.21 million compared to US$4.70 million in 2024 and a net loss of US$94.98 million versus US$96.92 million, while basic loss per share from continuing operations narrowed to US$0.35 from US$0.46. The combination of falling revenue and a slightly smaller loss highlights the company’s challenge of scaling its business while still tightly managing costs. With sales declining year over year but net loss narrowing, we’ll...
NYSE:SR
NYSE:SRGas Utilities

Spire’s US$11.2 Billion Decade-Long Investment Plan Might Change The Case For Investing In Spire (SR)

Zacks Equity Research recently highlighted Spire Inc.’s long-term infrastructure and innovation plans, including an expected US$11.20 billion in capital investments over the next decade, alongside its current 3.59% dividend yield and analyst estimates for long-term earnings growth. The analysis underscores how these planned investments and anticipated earnings expansion could influence Spire’s role in a gas utility sector balancing aging infrastructure, renewable competition, and the...
NYSE:MUX
NYSE:MUXMetals and Mining

McEwen Mining (MUX) Q4 Profit Jump Challenges Bearish Valuation Narratives

McEwen (MUX) closed out FY 2025 with Q4 revenue of US$64.6 million and basic EPS of US$0.70, alongside net income of US$38.1 million, putting a clear marker on its latest financial run rate. Over the year, quarterly revenue ranged from US$35.7 million in Q1 to US$64.6 million in Q4, while basic EPS moved between a loss of US$0.12 and a gain of US$0.70, giving investors a wide view of how profitability has tracked against the top line. Overall, the results point to firmer margins in the latest...
NYSE:CLVT
NYSE:CLVTProfessional Services

Clarivate Claude Tie Up Tests AI Disintermediation And Workflow Stickiness

Clarivate (NYSE:CLVT) has integrated its regulatory intelligence with Anthropic's Claude AI assistant. The collaboration embeds Clarivate's regulatory data directly into biopharma, biotech, and medtech AI workflows. The move is aimed at supporting regulatory affairs teams by keeping trusted data closer to day to day decision making. Clarivate focuses on data, analytics, and workflow tools for research driven industries, and life sciences is a core part of that mix. By plugging its...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial Eyes Stickier Revenue With New Antenna And Dealer Expansion

Hemisphere GNSS, a brand of CNH Industrial, has introduced the A65 GNSS antenna in partnership with Calian Group, targeting better interference rejection and easier upgrades for precision agriculture systems. Forrester Farm Equipment is acquiring AG-Industrial, expanding the CNH dealer network and deepening cooperation on parts and service support across North America. CNH Industrial (NYSE:CNH), trading at about $10.65, has a mixed recent performance, with a 13.9% return year to date but...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

A Look At Axsome Therapeutics (AXSM) Valuation As Legal Probe And FDA Decision Draw Investor Focus

Why Axsome’s Latest Legal and Regulatory Headlines Matter for Shareholders Axsome Therapeutics (AXSM) is back in focus as investors weigh a new shareholder investigation into past AXS-07 regulatory disclosures, alongside an upcoming FDA decision on AXS-05 for Alzheimer’s disease agitation. See our latest analysis for Axsome Therapeutics. At a share price of $156.08, Axsome’s 1 day share price return of 1.27% and 90 day share price return of 5.34% contrast with a 30 day share price return of a...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

First Beijing Investment Stake Reshapes Governance Debate At Luckin Coffee

First Beijing Investment Ltd has become a major shareholder in Luckin Coffee (OTCPK:LKNC.Y) after acquiring over 107,000,000 shares. The purchase gives First Beijing Investment Ltd control of more than 5% of the company, crossing the threshold for a significant ownership stake. This change in the shareholder base introduces a new institutional holder that could influence future discussions around governance and strategy. Luckin Coffee operates a large coffee chain footprint in China,...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

DENTSPLY SIRONA Bets On Dental MRI To Reframe Growth Story

DENTSPLY SIRONA (NasdaqGS:XRAY) and Siemens Healthineers secured FDA clearance for the MAGNETOM Free.Max Dental Edition, described as the first MRI system dedicated to dental use. The company is preparing for a US launch, supported by clinical trial data and upcoming training programs for dental professionals. The system is designed to offer high contrast, non ionizing imaging for applications such as endodontics and TMJ assessment. At a current share price of $11.54, DENTSPLY SIRONA comes...
NYSE:HNGE
NYSE:HNGEHealthcare

Is It Time To Reassess Hinge Health (HNGE) After Its Recent Share Price Rebound?

If you are wondering whether Hinge Health is attractively priced or already baking in a lot of optimism, this article is designed to help you frame that question clearly. The stock last closed at US$45.00, with a 16.1% gain over the past 30 days, but a 2.5% decline over the last week and a 1.2% decline year to date. This hints at shifting views on both its potential and its risks. Recent news coverage has focused on Hinge Health's position as a listed musculoskeletal care company, along with...
NYSE:CPA
NYSE:CPAAirlines

Is Copa Holdings (CPA) Pricing Reflect Long Term Latin American Air Travel Expectations

If you are wondering whether Copa Holdings at around US$110 per share is offering good value right now, looking closely at how it is priced versus its fundamentals can help you frame that decision. The stock has had a mixed run, with a 25.5% return over the last year and a 52.9% return over three years, alongside shorter term moves such as a 26.7% decline over the last 30 days and an 11.7% decline over the past week. Recent news around Copa Holdings has focused on its position in Latin...
NYSE:RDW
NYSE:RDWAerospace & Defense

NASA Grant Puts Redwire’s PIL-BOX Drug Research In Investor Focus

NASA awarded Redwire (NYSE: RDW) an additional US$4 million for drug development research on the International Space Station. The funding supports Redwire's Pharmaceutical In-space Laboratory, known as PIL-BOX, expanding its existing contract with NASA. The project focuses on using microgravity to study and manufacture potential future pharmaceutical treatments. For investors watching the space infrastructure theme, Redwire sits at the intersection of space hardware and applied research,...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Is Gibraltar Industries (ROCK) Now A Potential Opportunity After A 36.9% One Year Share Price Drop

Wondering whether Gibraltar Industries is starting to look like value at today’s price, or if the stock’s risks still outweigh the potential upside? This article is built to help you weigh that up using clear valuation checks. After closing at US$41.27, the stock has seen a 2.6% gain over the last 7 days. That sits against a 23.7% decline over 30 days and a 36.9% decline over the past year, with returns of 17.7% decline year to date, 11.2% decline over 3 years and 52.7% decline over 5...
NasdaqGS:TTAN
NasdaqGS:TTANSoftware

ServiceTitan (TTAN) Revenue Growth Of 26.5% Tests Bearish Profitability Narratives

ServiceTitan (TTAN) just posted another quarter of rapid top line expansion, with Q3 FY 2026 revenue at US$249.2 million and a basic EPS loss of US$0.42, against a backdrop of 26.5% revenue growth over the past year and a trailing twelve month net loss of US$298.1 million. The company has seen quarterly revenue move from US$192.9 million in Q2 FY 2025 to US$249.2 million in Q3 FY 2026. Over the same period, basic EPS losses ranged from US$1.43 in Q2 FY 2025 to US$0.42 in the latest quarter,...
NasdaqGS:LI
NasdaqGS:LIAuto

Has Li Auto (NasdaqGS:LI) Fallen Too Far After Recent 36.9% Share Price Slide

If you are wondering whether Li Auto's current share price still reflects its long term potential, you are not alone. Many investors are asking what the stock is really worth right now. The stock closed at US$17.33, with returns of 1.0% over 7 days, a 9.7% decline over 30 days, roughly flat year to date at 0.5%, and a 36.9% decline over the last year, which has shifted how some investors may be thinking about both upside potential and risk. Recent news flow around Li Auto has focused on...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

Performance Food Group Faces New Questions With Cheney Brothers US$42.5m Expansion

Cheney Brothers, a subsidiary of Performance Food Group, plans a $42.5 million expansion of its South Carolina distribution center. The project is expected to add new jobs in the region and support the integration of a recent acquisition. The expansion reflects Performance Food Group's focus on building out its distribution network and operational footprint. Performance Food Group (NYSE:PFGC) is drawing attention with this fresh capital commitment alongside a current share price of $88.18...
NYSE:ABX
NYSE:ABXInsurance

Abacus Global Management (ABX) Profitability Turn Reinforces Bullish Narrative Despite Valuation Tension

Abacus Global Management (ABX) has just wrapped up FY 2025 with fourth quarter revenue of US$71.9 million and basic EPS of US$0.07, rounding out a trailing twelve month EPS of US$0.38 on revenue of US$235.2 million. The company has seen quarterly revenue move from US$33.2 million and basic EPS of a loss of US$0.22 in Q4 2024 to US$71.9 million and EPS of US$0.07 in Q4 2025, while trailing twelve month net income shifted from a loss of US$24.0 million to a profit of US$36.5 million. This sets...